insiderwall
Menu
SuperinvestorInsider
Omnicell Inc. OMCL

Super Investor & Insider

Nessuna transazione insider negli ultimi 6 mesi.

Fondi: 13F-HR alla SEC. Insider: acquisti (P) e vendite (S) in borsa da SEC EDGAR, ultimi 12 mesi.

About

Omnicell Inc. operates as a provider of medication management solutions and adherence tools within the healthcare industry. Its primary function is to optimize medication management and supply chain processes in healthcare facilities, aiming to enhance safety and efficiency. The company offers automated dispensing syst

SectorHealthcare
ExchangeNASDAQ
IndustryHealth Information Services
CountryUnited States
Employees3,525
TickerOMCL

Statistics

Market Cap$1.76B
Revenue (TTM)$1.18B
Net Income$2.1M
Net Margin0.2%
EPS$0.04
P/E85.95
P/S1.40
P/B1.37
EV/EBITDA23.09
ROE1.6%
Dividend Yield
Price$38.76

Data: Twelve Data · Revenue = mcap / P/S